Regulatory note: Both peptides are research chemicals, not FDA-approved (removed from 503A compounding Category 2 in Sept 2024
The optimal dose depends on the formulation, enhancement strategy used, and research objectives
We also utilize an outcome tracker called OutcomeMD. This utilizes continuously updated questionnaires to monitor and evaluate changes in our patients symptoms and treatment outcomes
Most clinical applications use 600-2,400 mg/day [9][18][20]
Vegan and free from the following additives S-Acetyl-Glutathione capsules from Unimedica are, in accordance with legal requirements, free from additives such as colorants, stabilizers, preservatives, and separating agents like magnesium stearate
How retatrutide compares to approved medications Researchers naturally want to know how retatrutide measures against the GLP-1 medications already available